Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A
Chandrani Nath, Vishnu Nayak Badavath, Abhishek Thakur, et al.
MedChemComm (2018) Vol. 9, Iss. 7, pp. 1164-1171
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19
Suresh Gangadevi, Vishnu Nayak Badavath, Abhishek Thakur, et al.
The Journal of Physical Chemistry Letters (2021) Vol. 12, Iss. 7, pp. 1793-1802
Closed Access | Times Cited: 92
Pyrazoline Containing Compounds as Therapeutic Targets for Neurodegenerative Disorders
Mohamed Jawed Ahsan, Amena Ali, Abuzer Ali, et al.
ACS Omega (2022) Vol. 7, Iss. 43, pp. 38207-38245
Open Access | Times Cited: 37
Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (mpro): a molecular docking, molecular dynamics and structure-activity relationship studies
Vishnu Nayak Badavath, Akhil Kumar, Pralok K. Samanta, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 7, pp. 3110-3128
Open Access | Times Cited: 49
Monoamine oxidase A: An emerging therapeutic target in prostate cancer
Chia‐Hui Chen, Boyang Jason Wu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer’s disease
Bhanuranjan Das, Anurag T. K. Baidya, Sourabh Chakrabarti, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107373-107373
Closed Access | Times Cited: 5
Current Trends in Drug Delivery System of Curcumin and its Therapeutic Applications
Ayushi Sethiya, Dinesh K. Agarwal, Shikha Agarwal
Mini-Reviews in Medicinal Chemistry (2020) Vol. 20, Iss. 13, pp. 1190-1232
Closed Access | Times Cited: 33
Design and various in silico studies of the novel curcumin derivatives as potential candidates against COVID-19 -associated main enzymes
Hakan Alıcı, Hakan Tahtacı, Kadir Demır
Computational Biology and Chemistry (2022) Vol. 98, pp. 107657-107657
Open Access | Times Cited: 19
Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents
Manohar Mantipally, Madhusudhana Reddy Gangireddy, Rambabu Gundla, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 16, pp. 2248-2253
Closed Access | Times Cited: 35
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation
Davide Moi, Alessio Nocentini, Alessandro Deplano, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111638-111638
Open Access | Times Cited: 31
Primer for Designing Main Protease (Mpro) Inhibitors of SARS-CoV-2
Abhishek Thakur, Gaurav Sharma, Vishnu Nayak Badavath, et al.
The Journal of Physical Chemistry Letters (2022) Vol. 13, Iss. 25, pp. 5776-5786
Closed Access | Times Cited: 16
Design and Synthesis of Piperazine‐Linked Imidazo[1,2‐a]pyridine Derivatives as Potent Anticancer Agents
Madhusudhana Reddy Gangireddy, Manohar Mantipally, Rambabu Gundla, et al.
ChemistrySelect (2019) Vol. 4, Iss. 46, pp. 13622-13629
Closed Access | Times Cited: 27
Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives
Mohd Usman Mohd Siddique, Abhishek Thakur, Deepak Shilkar, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113630-113630
Closed Access | Times Cited: 23
Tuning Caco-2 permeability by cocrystallization: Insights from molecular dynamics simulation
Noopur Pandey, Nimmy Kumari, Parag Roy, et al.
International Journal of Pharmaceutics (2023) Vol. 650, pp. 123666-123666
Closed Access | Times Cited: 8
Novel α-Aminophosphonates of imatinib Intermediate: Synthesis, anticancer Activity, human Abl tyrosine kinase Inhibition, ADME and toxicity prediction
Saikiran Aita, Vishnu Nayak Badavath, Mohan Gundluru, et al.
Bioorganic Chemistry (2021) Vol. 109, pp. 104718-104718
Closed Access | Times Cited: 20
Synthesis, spectral investigation, molecular docking and biological evaluation of Cu(II), Ni(II) and Mn(II) complexes of (E)-2-((2-butyl-4-chloro-1H-imidazol-5-yl)methylene)-N-methylhydrazinecarbothioamide (C10H16N5ClS) and its DFT studies
A. Sreenath Reddy, Jincheng Mao, Sivarama Krishna Lakkaboyana, et al.
Journal of Molecular Structure (2019) Vol. 1196, pp. 338-347
Closed Access | Times Cited: 21
Synthesis, characterization, and antimicrobial activity of novel ferrocene-containing 1-(thio)acetyl pyrazolines
Anka Todosijević, Jovana Bugarinović, Marko Pešić, et al.
Polyhedron (2024) Vol. 258, pp. 117028-117028
Closed Access | Times Cited: 2
Novel halogenated pyrido[2,3-a]carbazoles with enhanced aromaticity as potent anticancer and antioxidant agents: rational design and microwave assisted synthesis
Munusamy Saravanabhavan, Vishnu Nayak Badavath, Siddhartha Maji, et al.
New Journal of Chemistry (2019) Vol. 43, Iss. 44, pp. 17231-17240
Closed Access | Times Cited: 18
A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Potencies
Nisha Abdul Rehuman, Bijo Mathew, Rakesh Kumar Jat, et al.
Combinatorial Chemistry & High Throughput Screening (2020) Vol. 23, Iss. 9, pp. 898-914
Closed Access | Times Cited: 16
Design, synthesis, cytotoxic evaluation and molecular docking studies of novel thiazolyl α-aminophosphonates
Mohan Gundluru, Vishnu Nayak Badavath, Haroon Yasmin Shaik, et al.
Research on Chemical Intermediates (2020) Vol. 47, Iss. 3, pp. 1139-1160
Closed Access | Times Cited: 12
Synthesis and evaluation of new pyrazoline‐thiazole derivatives as monoamine oxidase inhibitors
Ulviye Acar Çevik, Derya Osmani̇ye, Begüm Nurpelin Sağlık, et al.
Journal of Heterocyclic Chemistry (2019) Vol. 56, Iss. 11, pp. 3000-3007
Closed Access | Times Cited: 11
Brain permeable curcumin-based pyrazoline analogs: MAO inhibitory and antioxidant activity
Vishnu Nayak Badavath, Abhishek Thakur, Deepak Shilkar, et al.
Journal of Molecular Structure (2022) Vol. 1268, pp. 133681-133681
Closed Access | Times Cited: 5
Biological Evaluation of 2-aminothiazole Hybrid as Antimalarial and Antitrypanosomal Agents: Design and Synthesis
Surender Singh Jadav, Vishnu Nayak Badavath, Ramesh Ganesan, et al.
Anti-Infective Agents (2018) Vol. 18, Iss. 2, pp. 101-108
Closed Access | Times Cited: 6
Design, synthesis and molecular docking of piperidin‐4‐amine linked pyrimidine derivatives as potent anticancer agents
Madhu Sudhana Reddy Gangireddy, Manohar Mantipally, Vishnu Nayak Badavath, et al.
Chemical Data Collections (2021) Vol. 32, pp. 100646-100646
Closed Access | Times Cited: 6
Computational Studies of bis-2-Oxoindoline Succinohydrazides and their In Vitro Cytotoxicity
Ravi Jarapula, Vishnu Nayak Badavath, Shriram Rekulapally, et al.
Current Computer - Aided Drug Design (2019) Vol. 16, Iss. 3, pp. 270-280
Closed Access | Times Cited: 4
In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease
Manoj Kumar Vashisth, Junkai Hu, Mingrui Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top